University of Chicago
Chicago, IL
- Fellowship - Gynecologic Oncology
2023
Temple University Hospital
Philadelphia, PA
- Residency - OB/GYN
2020
University of Rochester SMD
Rochester, NY
MD
2016
University at Buffalo SPHHP
Buffalo, NY
MPH - Health Services Administration
2012
University of Rochester
Rochester, NY
BS - Biochemistry
2011
University of Rochester
Rochester, NY
BA - Statistics
2011
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center.
Race and neighborhood disadvantage in patients with stage I-III endometrioid endometrial carcinoma treated at a tertiary referral center. Gynecol Oncol. 2025 Oct; 201:203-209.
PMID: 40911974
Analysis of racial differences in HER2 status and molecular subtype in grade 3 endometroid endometrial carcinoma.
Analysis of racial differences in HER2 status and molecular subtype in grade 3 endometroid endometrial carcinoma. Gynecol Oncol Rep. 2025 Oct; 61:101936.
PMID: 40951324
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause.
A cell atlas of the human fallopian tube throughout the menstrual cycle and menopause. Nat Commun. 2025 01 03; 16(1):372.
PMID: 39753552
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer.
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer. Am J Obstet Gynecol. 2025 Mar; 232(3):308.e1-308.e15.
PMID: 39245428
The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions.
The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions. Gynecol Oncol Rep. 2024 Feb; 51:101328.
PMID: 38318201
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing.
A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencing. Cell Rep. 2022 12 20; 41(12):111838.
PMID: 36543131
Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.
Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma. Gynecol Oncol. 2023 02; 169:164-171.
PMID: 36333181
Surviving and thriving: What do survivors of gynecologic cancer want?
Surviving and thriving: What do survivors of gynecologic cancer want? Gynecol Oncol Rep. 2022 Jun; 41:101011.
PMID: 35663850
Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19.
Lessons learned: Telemedicine patterns and clinical application in patients with gynecologic cancers during COVID-19. Gynecol Oncol Rep. 2022 Jun; 41:100986.
PMID: 35540027
A look at the gynecologic oncologist workforce - Are we meeting patient demand?
A look at the gynecologic oncologist workforce - Are we meeting patient demand? Gynecol Oncol. 2021 11; 163(2):229-236.
PMID: 34456058